U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.
Veracyte, Inc. , a leading cancer diagnostics company, today announced new data that reinforce the ability of its Decipher Bladder Genomic Subtyping Classifier to help improve staging for patients ...
Investigators from the Food and Drug Administration are working on a new Salmonella outbreak of unknown origin. The ...
Acrivon Therapeutics (ACRV) announced the U.S. Food and Drug Administration, FDA, has granted Breakthrough Device designation, BDD, for the ...
Kura Oncology (KURA) and Kyowa Kirin announced topline results from KOMET-001, the Phase 2 registration-directed trial of ziftomenib, a highly ...
Recently, the Government Accountability Office issued a report calling for a unified food safety strategy. There aren’t too ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).
19h
Positive Feedback on Phase III Trial Design LONDON, Feb. 5, 2025 /PRNewswire/ -- Serac Healthcare Limited (Serac Healthcare ...
Following a recent revoking of authorization by the Food and Drug Association (FDA), manufacturers choice of FD&C Red No. 3, ...
Welcome to the full-year 2024 Novo Nordisk earnings conference call. [Operator instructions] Please be advised that today's ...
Inspiratm Technologies OXY B.H.N. Ltd. ("Inspira" or the "Company"), a pioneer in breakthrough life-support technology, today announced the integration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback